Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CXCR2 is a G-protein-coupled receptor (GPCR) that primarily functions as a receptor for several CXC chemokines, most notably interleukin-8 (IL-8, also known as CXCL8). It plays critical roles in immune cell migration, inflammation, cancer progression, and central nervous system development. Upon ligand binding, CXCR2 activates PI3K/Akt, PLC/PKC, and MAPK/p38 pathways, leading to cell migration, proliferation, and survival. Targeting this receptor is under investigation for therapeutic intervention in inflammatory diseases and cancer.
Receptor antagonist, inverse agonist
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CXC chemokine receptor 2 (CXCR2).